The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Obesity, kidney dysfunction, and inflammation: interactions in hypertension
Open accessAbstract
Obesity contributes 65–75% of the risk for human primary (essential) hypertension (HT) which is a major driver of cardiovascular and kidney diseases. Kidney dysfunction, associated with increased renal sodium reabsorption and compensatory glomerular hyperfiltration, plays a key role in initiating obesity-HT and target organ injury. Mediators of kidney dysfunction and increased blood pressure include (i) elevated renal sympathetic nerve activity (RSNA); (ii) increased antinatriuretic hormones such as angiotensin II and aldosterone; (iii) relative deficiency of natriuretic hormones; (iv) renal compression by fat in and around the kidneys; and (v) activation of innate and adaptive immune cells that invade tissues throughout the body, producing inflammatory cytokines/chemokines that contribute to vascular and target organ injury, and exacerbate HT. These neurohormonal, renal, and inflammatory mechanisms of obesity-HT are interdependent. For example, excess adiposity increases the adipocyte-derived cytokine leptin which increases RSNA by stimulating the central nervous system proopiomelanocortin-melanocortin 4 receptor pathway. Excess visceral, perirenal and renal sinus fat compress the kidneys which, along with increased RSNA, contribute to renin–angiotensin–aldosterone system activation, although obesity may also activate mineralocorticoid receptors independent of aldosterone. Prolonged obesity, HT, metabolic abnormalities, and inflammation cause progressive renal injury, making HT more resistant to therapy and often requiring multiple antihypertensive drugs and concurrent treatment of dyslipidaemia, insulin resistance, diabetes, and inflammation. More effective anti-obesity drugs are needed to prevent the cascade of cardiorenal, metabolic, and immune disorders that threaten to overwhelm health care systems as obesity prevalence continues to increase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“Although changes in diet and subsequent weight gain can alter GM, a causal role for GM dysbiosis in obesity has also been suggested by GM transplantation experiments.(107) Complex interactions among GM, the immune system, inflammation, and vascular dysfunction in the kidneys and brain have been hypothesized for HT.”
The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology
Aziz, F., & Chaudhary, K. (2017) · Cardiorenal Medicine · doi:10.1159/000450796 · Cited by 3,267
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
Kovesdy, C. P., Furth, S. L., Zoccali, C., & on behalf of the World Kidney Day Steering Committee (2017) · American Journal of Nephrology · doi:10.1159/000458467 · Cited by 2,217
Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity
Ward, Z. J., Bleich, S. N., Cradock, A. L., Barrett, J. L., Giles, C. M., Flax, C., Long, M. W., & Gortmaker, S. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmsa1909301 · Cited by 2,009
Obesity Phenotypes, Diabetes, and Cardiovascular Diseases
Piché, M.-E., Tchernof, A., & Després, J.-P. (2020) · Circulation Research · doi:10.1161/circresaha.120.316101 · Cited by 1,986
Obesity is associated with hypothalamic injury in rodents and humans.
Thaler, J. P., Yi, C.-X., Schur, E. A., Guyenet, S. J., Hwang, B. H., Dietrich, M. O., Zhao, X., Sarruf, D. A., Izgur, V., Maravilla, K. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59660 · Cited by 1,857
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,807
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736
Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period
Field, A. E., Coakley, E. H., Must, A., Spadano, J. L., Laird, N., Dietz, W. H., Rimm, E., & Colditz, G. A. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1581 · Cited by 1,694
Javaheri, S., Barbe, F., Campos-Rodriguez, F., Dempsey, J. A., Khayat, R., Javaheri, S., Malhotra, A., Martinez-Garcia, M. A., Mehra, R., Pack, A. I., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.069 · Cited by 1,434
Adipogenesis and metabolic health
Ghaben, A. L., & Scherer, P. E. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0093-z · Cited by 1,395
Body Mass Index and Risk for End-Stage Renal Disease
Hsu, C.-Y., McCulloch, C. E., Iribarren, C., Darbinian, J., & Go, A. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00006 · Cited by 1,390
Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360
Self-citationSalt-responsive gut commensal modulates TH17 axis and disease
Wilck, N., Matus, M. G., Kearney, S. M., Olesen, S. W., Forslund, K., Bartolomaeus, H., Haase, S., Mähler, A., Balogh, A., Markó, L., et al. (2017) · Nature · doi:10.1038/nature24628 · Cited by 1,310 · cited 3×
“In healthy humans, high-salt intake for 2 weeks decreased intestinal survival of Lactobacillus and increased BP, although a cause and effect relationship was not established.(109) However, BP reduction in SHR after ACE inhibition reduced mucosal permeability, inflammation, and dysbiosis(110) suggesting that GM changes…”
BackgroundInfluentialWilliams, B., MacDonald, T. M., Morant, S., Webb, D. J., Sever, P., McInnes, G., Ford, I., Cruickshank, J. K., Caulfield, M. J., Salsbury, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00257-3 · Cited by 1,308
Whelton, P. K., Appel, L. J., Espeland, M. A., Applegate, W. B., Ettinger, Jr., Kostis, J. B., Kumanyika, S., Lacy, C. R., Johnson, K. C., Folmar, S., et al. (1998) · JAMA · doi:10.1001/jama.279.11.839 · Cited by 1,200
Blüher, M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa004 · Cited by 1,090 · cited 1×
“Others have proposed the concept of metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) based on clinical observations that a subgroup of people with BMI >_ 30 do not exhibit obvious cardiometabolic abnormalities.(25,26) Fat location is important in determining cardiometabolic health and accu…”
BackgroundMetabolic Inflammation and Insulin Resistance in Obesity
Wu, H., & Ballantyne, C. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315896 · Cited by 1,059
Impact of Obesity on Plasma Natriuretic Peptide Levels
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Wilson, P. W. F., & Vasan, R. S. (2004) · Circulation · doi:10.1161/01.cir.0000112582.16683.ea · Cited by 1,022
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2018.06.010 · Cited by 947
Stevens, V. J., Obarzanek, E., Cook, N. R., Lee, I.-M., Appel, L. J., Smith West, D., Milas, N. C., Mattfeldt-Beman, M., Belden, L., Bragg, C., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-1-200101020-00007 · Cited by 886 · cited 1×
“In larger clinical trials, sodium restriction reduced BP, albeit modestly and with significant variability, in obese individuals.(152,153) These differences in salt-sensitivity are perhaps predictable, considering the multiple factors that determine BP response to changes in sodium intake and the different protocols u…”
BackgroundNeeland, I. J., Poirier, P., & Després, J.-P. (2018) · Circulation · doi:10.1161/circulationaha.117.029617 · Cited by 881
Incidence and precursors of hypertension in young adults: The Framingham offspring study
Garrison, R. J., Kannel, W. B., Stokes, J., & Castelli, W. P. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90087-9 · Cited by 789
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753
Ozata, M., Ozdemir, I. C., & Licinio, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.5999 · Cited by 739
Targeting inflammation in the treatment of type 2 diabetes: time to start
Donath, M. Y. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4275 · Cited by 690
Chronic Leptin Infusion Increases Arterial Pressure
Shek, E. W., Brands, M. W., & Hall, J. E. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.409 · Cited by 686
Self-citationObesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654
Self-citationMetabolically healthy obesity: facts and fantasies
Smith, G. I., Mittendorfer, B., & Klein, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129186 · Cited by 645
Intermittent Hypoxemia and OSA
Dewan, N. A., Nieto, F. J., & Somers, V. K. (2015) · Chest · doi:10.1378/chest.14-0500 · Cited by 641
The Effect of Weight Loss on the Sensitivity of Blood Pressure to Sodium in Obese Adolescents
Rocchini, A. P., Key, J., Bondie, D., Chico, R., Moorehead, C., Katch, V., & Martin, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908313210905 · Cited by 621
The Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
Functional and Structural Changes in the Kidney in the Early Stages of Obesity
HENEGAR, J. R., BIGLER, S. A., HENEGAR, L. K., TYAGI, S. C., & HALL, J. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261211 · Cited by 549
Self-citationMouton, A. J., Li, X., Hall, M. E., & Hall, J. E. (2020) · Circulation Research · doi:10.1161/circresaha.119.312321 · Cited by 546
Self-citationCauses, consequences, and treatment of metabolically unhealthy fat distribution
Stefan, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30110-8 · Cited by 541
Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins
Hall, J. E., da Silva, A. A., do Carmo, J. M., Dubinion, J., Hamza, S., Munusamy, S., Smith, G., & Stec, D. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.113175 · Cited by 528
Self-citationHypertension-Linked Pathophysiological Alterations in the Gut
Santisteban, M. M., Qi, Y., Zubcevic, J., Kim, S., Yang, T., Shenoy, V., Cole-Jeffrey, C. T., Lobaton, G. O., Stewart, D. C., Rubiano, A., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.309006 · Cited by 525
DeFuria, J., Belkina, A. C., Jagannathan-Bogdan, M., Snyder-Cappione, J., Carr, J. D., Nersesova, Y. R., Markham, D., Strissel, K. J., Watkins, A. A., Zhu, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215840110 · Cited by 521 · cited 1×
“B lymphocytes also accumulate in VAT of obese mice and produce inflammatory cytokines.(118) Immune cell-mediated inflammation in VAT, liver, and skeletal muscle has been proposed to play a major role in obesity-associated metabolic disorders, including insulin resistance and T2D.”
BackgroundObesity, hypertension, and chronic kidney disease
Hall, J., Juncos, L., Wang, Z., Hall, M., do Carmo, J., & da Silva, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s39739 · Cited by 520
Self-citationSex differences in cardiometabolic disorders
Gerdts, E., & Regitz-Zagrosek, V. (2019) · Nature Medicine · doi:10.1038/s41591-019-0643-8 · Cited by 519
Leptin in the interplay of inflammation, metabolism and immune system disorders
Abella, V., Scotece, M., Conde, J., Pino, J., Gonzalez-Gay, M. A., Gómez-Reino, J. J., Mera, A., Lago, F., Gómez, R., & Gualillo, O. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.209 · Cited by 497
Sex-specific differences in hypertension and associated cardiovascular disease
Colafella, K. M. M., & Denton, K. M. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.189 · Cited by 490
Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
Kühnen, P., Clément, K., Wiegand, S., Blankenstein, O., Gottesdiener, K., Martini, L. L., Mai, K., Blume-Peytavi, U., Grüters, A., & Krude, H. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512693 · Cited by 485
Pathophysiological role of leptin in obesity-related hypertension
Aizawa-Abe, M., Ogawa, Y., Masuzaki, H., Ebihara, K., Satoh, N., Iwai, H., Matsuoka, N., Hayashi, T., Hosoda, K., Inoue, G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8341 · Cited by 477
Eckel, N., Li, Y., Kuxhaus, O., Stefan, N., Hu, F. B., & Schulze, M. B. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30137-2 · Cited by 457
Obesity as a Disease: The Obesity Society 2018 Position Statement
Jastreboff, A. M., Kotz, C. M., Kahan, S., Kelly, A. S., & Heymsfield, S. B. (2019) · Obesity · doi:10.1002/oby.22378 · Cited by 457 · cited 1×
“Several organizations, including the World Obesity Federation, the Obesity Society, and the American Medical Association, have declared that obesity is a chronic, relapsing progressive disease.(24) Others have proposed the concept of metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) based o…”
BackgroundYang, H., Youm, Y.-H., Vandanmagsar, B., Ravussin, A., Gimble, J. M., Greenway, F., Stephens, J. M., Mynatt, R. L., & Dixit, V. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000021 · Cited by 440
Nazare, J.-A., Smith, J. D., Borel, A.-L., Haffner, S. M., Balkau, B., Ross, R., Massien, C., Alméras, N., & Després, J.-P. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.035758 · Cited by 437
An Integrated View of Immunometabolism
Lee, Y. S., Wollam, J., & Olefsky, J. M. (2018) · Cell · doi:10.1016/j.cell.2017.12.025 · Cited by 436
Immune mechanisms of hypertension
Drummond, G. R., Vinh, A., Guzik, T. J., & Sobey, C. G. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0160-5 · Cited by 428
Targeting innate immune mediators in type 1 and type 2 diabetes
Donath, M. Y., Dinarello, C. A., & Mandrup-Poulsen, T. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0213-9 · Cited by 416
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
Muskiet, M. H. A., Tonneijck, L., Smits, M. M., van Baar, M. J. B., Kramer, M. H. H., Hoorn, E. J., Joles, J. A., & van Raalte, D. H. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.123 · Cited by 407
The immunology of hypertension
Norlander, A. E., Madhur, M. S., & Harrison, D. G. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171773 · Cited by 399
Mechanisms of Obesity-Associated Cardiovascular and Renal Disease
Hall, J. E., Crook, E. D., Jones, D. W., Wofford, M. R., & Dubbert, P. M. (2002) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200209000-00003 · Cited by 373
Self-citationRole of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited
da Silva, A. A., do Carmo, J. M., Li, X., Wang, Z., Mouton, A. J., & Hall, J. E. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.066 · Cited by 368
Self-citationLeptin and the maintenance of elevated body weight
Pan, W. W., & Myers, M. G. (2018) · Nature reviews. Neuroscience · doi:10.1038/nrn.2017.168 · Cited by 344
Global Health Effects of Overweight and Obesity
Gregg, E. W., & Shaw, J. E. (2017) · New England Journal of Medicine · doi:10.1056/nejme1706095 · Cited by 341
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled
BRAMLAGE, P., PITTROW, D., WITTCHEN, H., KIRCH, W., BOEHLER, S., LEHNERT, H., HOEFLER, M., UNGER, T., & SHARMA, A. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.05.017 · Cited by 328
Ilan, Y., Maron, R., Tukpah, A.-M., Maioli, T. U., Murugaiyan, G., Yang, K., Wu, H. Y., & Weiner, H. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908771107 · Cited by 327
(2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70156-1 · Cited by 319
MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency
Clément, K., Biebermann, H., Farooqi, I. S., Van der Ploeg, L., Wolters, B., Poitou, C., Puder, L., Fiedorek, F., Gottesdiener, K., Kleinau, G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0015-9 · Cited by 309
Renal Denervation Attenuates the Sodium Retention and Hypertension Associated With Obesity
Kassab, S., Kato, T., Wilkins, F. C., Chen, R., Hall, J. E., & Granger, J. P. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.893 · Cited by 307
Self-citationMahfoud, F., Böhm, M., Schmieder, R., Narkiewicz, K., Ewen, S., Ruilope, L., Schlaich, M., Williams, B., Fahy, M., & Mancia, G. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz118 · Cited by 297
Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity
Carlyle, M., Jones, O. B., Kuo, J. J., & Hall, J. E. (2002) · Hypertension · doi:10.1161/hy0202.104398 · Cited by 292
Self-citationObesity and hypertension: two epidemics or one?
Davy, K. P., & Hall, J. E. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00707.2003 · Cited by 280
Self-citationHigh Salt Intake: Independent Risk Factor for Obesity?
Ma, Y., He, F. J., & MacGregor, G. A. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05948 · Cited by 278
Shihab, H. M., Meoni, L. A., Chu, A. Y., Wang, N.-Y., Ford, D. E., Liang, K.-Y., Gallo, J. J., & Klag, M. J. (2012) · Circulation · doi:10.1161/circulationaha.112.117333 · Cited by 274
Is obesity a major cause of chronic kidney disease?
Hall, J. E., Henegar, J. R., Dwyer, T. M., Liu, J., da Silva, A. A., Kuo, J. J., & Tallam, L. (2004) · Advances in Renal Replacement Therapy · doi:10.1053/j.arrt.2003.10.007 · Cited by 264
Self-citationEthnic Differences in the Association between Body Mass Index and Hypertension
Colin Bell, A. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.346 · Cited by 250
Chen, J., Gu, D., Huang, J., Rao, D. C., Jaquish, C. E., Hixson, J. E., Chen, C.-S., Chen, J., Lu, F., Hu, D., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60144-6 · Cited by 249
Herrera, J., Ferrebuz, A., MacGregor, E. G., & Rodriguez-Iturbe, B. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080918 · Cited by 233
Hypertension: Physiology and Pathophysiology
Hall, J. E., Granger, J. P., do Carmo, J. M., da Silva, A. A., Dubinion, J., George, E., Hamza, S., Speed, J., & Hall, M. E. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110058 · Cited by 232
Self-citationObesity and Cardiac Remodeling in Adults: Mechanisms and Clinical Implications
Alpert, M. A., Karthikeyan, K., Abdullah, O., & Ghadban, R. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.07.012 · Cited by 221
Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB
Purkayastha, S., Zhang, G., & Cai, D. (2011) · Nature Medicine · doi:10.1038/nm.2372 · Cited by 220
Health Effects of Overweight and Obesity in 195 Countries
(2017) · New England Journal of Medicine · doi:10.1056/nejmc1710026 · Cited by 219
Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration
de Paula, R. B., da Silva, A. A., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000105624.68174.00 · Cited by 207 · cited 1×
“In obese dogs, MR antagonism blunted renal sodium reabsorption, glomerular hyperfiltration, and HT by >50%.(93) MR antagonists also de-”
BackgroundSelf-citationImmunologic and endocrine functions of adipose tissue: implications for kidney disease
Zhu, Q., & Scherer, P. E. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.157 · Cited by 200 · cited 2×
“Although excessive weight gain and increased adiposity initially cause modest increases in BP, obesity-induced metabolic and inflammatory disorders interact with HT to promote gradual injury to blood vessels and various organs, including the heart and kidneys.(6,120,156,157) The impact of obesity on chronic kidney dis…”
BackgroundSeals, D. R., Tanaka, H., Clevenger, C. M., Monahan, K. D., Reiling, M. J., Hiatt, W. R., Davy, K. P., & DeSouza, C. A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01348-1 · Cited by 187
Loperena, R., Van Beusecum, J. P., Itani, H. A., Engel, N., Laroumanie, F., Xiao, L., Elijovich, F., Laffer, C. L., Gnecco, J. S., Noonan, J., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy112 · Cited by 187
Natriuretic peptides in cardiometabolic regulation and disease
Zois, N. E., Bartels, E. D., Hunter, I., Kousholt, B. S., Olsen, L. H., & Goetze, J. P. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.64 · Cited by 182
Mattson, D. L., Lund, H., Guo, C., Rudemiller, N., Geurts, A. M., & Jacob, H. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00304.2012 · Cited by 178
Pareek, M., Schauer, P. R., Kaplan, L. M., Leiter, L. A., Rubino, F., & Bhatt, D. L. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.014 · Cited by 177
Hart, E. C., Head, G. A., Carter, J. R., Wallin, B. G., May, C. N., Hamza, S. M., Hall, J. E., Charkoudian, N., & Osborn, J. W. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00703.2016 · Cited by 167
Self-citationSelective leptin resistance revisited
Mark, A. L. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00180.2013 · Cited by 162 · cited 23×
“In the CNS, leptin stimulates janus tyrosine kinase 2 (JAK2) activity and three intracellular signalling pathways.73 Signal transducers and activators of transcription 3 (STAT3) plays a major role in mediating the effects of leptin on food intake and overall energy balance.30,35 Insulin receptor substrate 2 (IRS2)-pho…”
BackgroundInfluentialImpact of Body Weight on Blood Pressure With a Focus on Sex Differences: The Tromsø Study, 1986-1995
Wilsgaard, T., Schirmer, H., & Arnesen, E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2847 · Cited by 158
Müller, D. N., Mervaala, E. M. A., Schmidt, F. H., Park, J.-K., Dechend, R., Genersch, E., Breu, V., Löffler, B., Ganten, D., Schneider, W., et al. (2000) · Hypertension · doi:10.1161/01.hyp.36.2.282 · Cited by 158
Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension
Hall, J. E. (2016) · Circulation · doi:10.1161/circulationaha.115.018526 · Cited by 152
Self-citationAngiotensin II–Induced Hypertension Is Modulated by Nuclear Factor-κB in the Paraventricular Nucleus
Cardinale, J. P., Sriramula, S., Mariappan, N., Agarwal, D., & Francis, J. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.182154 · Cited by 149
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies
Grassi, G. M., Biffi, A., Seravalle, G., Trevano, F. Q., Dell’Oro, R., Corrao, G., & Mancia, G. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12885 · Cited by 148
Zelissen, P. M. J., Stenlof, K., Lean, M. E. J., Fogteloo, J., Keulen, E. T. P., Wilding, J., Finer, N., Rössner, S., Lawrence, E., Fletcher, C., et al. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00468.x · Cited by 144
Harlan, S. M., Morgan, D. A., Agassandian, K., Guo, D.-F., Cassell, M. D., Sigmund, C. D., Mark, A. L., & Rahmouni, K. (2011) · Circulation Research · doi:10.1161/circresaha.111.240226 · Cited by 144
Leptin Signaling in the Nucleus Tractus Solitarii Increases Sympathetic Nerve Activity to the Kidney
Mark, A. L., Agassandian, K., Morgan, D. A., Liu, X., Cassell, M. D., & Rahmouni, K. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.124255 · Cited by 139
Melanocortin-4 Receptor Mediates Chronic Cardiovascular and Metabolic Actions of Leptin
Tallam, L. S., da Silva, A. A., & Hall, J. E. (2006) · Hypertension · doi:10.1161/01.hyp.0000227966.36744.d9 · Cited by 133
Self-citationImmune mechanisms of salt-sensitive hypertension and renal end-organ damage
Mattson, D. L. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0121-z · Cited by 133
Egan, B. M., Stepniakowski, K. T., & Goodfriend, T. L. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.10.886 · Cited by 129
do Carmo, J. M., da Silva, A. A., Cai, Z., Lin, S., Dubinion, J. H., & Hall, J. E. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.161349 · Cited by 127
Self-citationNiewiński, P., Janczak, D., Ruciński, A., Tubek, S., Engelman, Z. J., Piesiak, P., Jaźwiec, P., Banasiak, W., Fudim, M., Sobotka, P. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.641 · Cited by 126
Mechanism of Salt-Sensitive Hypertension: Focus on Adrenal and Sympathetic Nervous Systems
Fujita, T. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121258 · Cited by 124
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
Aydin, Ö., Nieuwdorp, M., & Gerdes, V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1020-6 · Cited by 124
Rapid Onset of Renal Sympathetic Nerve Activation in Rabbits Fed a High-Fat Diet
Armitage, J. A., Burke, S. L., Prior, L. J., Barzel, B., Eikelis, N., Lim, K., & Head, G. A. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190413 · Cited by 115
Inhibition of NO Synthesis Enhances Chronic Cardiovascular and Renal Actions of Leptin
Kuo, J. J., Jones, O. B., & Hall, J. E. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.670 · Cited by 114
Self-citationHypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function
Kuo, J. J., Silva, A. A., & Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000048194.97428.1a · Cited by 113
Self-citationChemoreflexes, Sleep Apnea, and Sympathetic Dysregulation
Mansukhani, M. P., Kara, T., Caples, S. M., & Somers, V. K. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0476-2 · Cited by 112
Is a Re-evaluation of Who Body Mass Index Cut-off Values Needed? the Case of Asians in Singapore
Deurenberg‐Yap, M., & Deurenberg, P. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.may.s80-s87 · Cited by 109
Suppressing adipocyte inflammation promotes insulin resistance in mice
Zhu, Q., An, Y., Kim, M., Zhang, Z., Zhao, S., Zhu, Y., Asterholm, I. W., Kusminski, C. M., & Scherer, P. E. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101010 · Cited by 104
High Perfusion Pressure Accelerates Renal Injury in Salt-Sensitive Hypertension
Mori, T., Polichnowski, A. J., Glocka, P., Kaldunski, M. L., Ohsaki, Y., Liang, M., & Cowley, A. W. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121271 · Cited by 99
Reduced parasympathetic control of heart rate in obese dogs
Van Vliet, B. N., Hall, J. E., Mizelle, H. L., Montani, J. P., & Smith, M. J. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.2.h629 · Cited by 95 · cited 2×
“obesity-HT, with increased heart rate (HR) due mainly to decreased parasympathetic activity.(37,39) Age, sex, ethnicity, and differences in fat distribution contribute to”
BackgroundSelf-citationObesity-Related Hypertension and the Role of Insulin and Leptin in High-Fat–Fed Rabbits
Lim, K., Burke, S. L., & Head, G. A. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00705 · Cited by 95
Faulkner, J., Bruder-Nascimento, T. B., & de Chantemèle, E. J. B. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000384 · Cited by 90
Catheter-Based Radiorefrequency Renal Denervation Lowers Blood Pressure in Obese Hypertensive Dogs
Henegar, J. R., Zhang, Y., Rama, R. D., Hata, C., Hall, M. E., & Hall, J. E. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu048 · Cited by 89
Self-citationPartial leptin deficiency confers resistance to diet-induced obesity in mice
Zhao, S., Li, N., Zhu, Y., Straub, L. G., Zhang, Z., Wang, M.-Y., Zhu, Q., Kusminski, C. M., Elmquist, J. K., & Scherer, P. E. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.100995 · Cited by 89
Structural Renal Changes in Obesity and Diabetes
Amann, K., & Benz, K. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.003 · Cited by 86 · cited 3×
“Early in obesity development, there is microalbuminuria, interstitial fibrosis, increased mesangial matrix, glomerulomegaly, focal glomerulosclerosis, and podocyte abnormalities associated with glomerular hyperfiltration.160–162 When obesity-HT and metabolic abnormalities are maintained over several years, gradual nep…”
BackgroundSympathetic Function in Human Carriers of Melanocortin-4 Receptor Gene Mutations
Sayk, F., Heutling, D., Dodt, C., Iwen, K. A., Wellhoner, J. P., Scherag, S., Hinney, A., Hebebrand, J., & Lehnert, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2297 · Cited by 86
Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With Hypertension
Sardar, P., Bhatt, D. L., Kirtane, A. J., Kennedy, K. F., Chatterjee, S., Giri, J. S., Soukas, P. A., White, W. B., Parikh, S. A., & Aronow, H. D. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.082 · Cited by 86
Apparent mineralocorticoid excess
Funder, J. W. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.010 · Cited by 83 · cited 1×
“thelial intracellular redox state, increased Rac1, and decreased 11bHSD2 could all contribute to MR activation in obesity.(8,99) However, the”
BackgroundCatheter-Based Radiofrequency Renal Denervation: Location Effects on Renal Norepinephrine
Henegar, J. R., Zhang, Y., Hata, C., Narciso, I., Hall, M. E., & Hall, J. E. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpu258 · Cited by 83 · cited 1×
“These results underestimate BP effects of RDN since catheterbased RDN typically causes <40–50% renal nerve ablation unless nerves in renal segmental arteries are ablated.(44,47)”
BackgroundSelf-citationda Silva, A. A., do Carmo, J. M., Kanyicska, B., Dubinion, J., Brandon, E., & Hall, J. E. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100636 · Cited by 79
Self-citationBurton, J. O., Gray, L. J., Webb, D. R., Davies, M. J., Khunti, K., Crasto, W., Carr, S. J., & Brunskill, N. J. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr574 · Cited by 77
Obesity-associated hypertension. Hyperinsulinemia and renal mechanisms.
Hall, J. E., Brands, M. W., Hildebrandt, D. A., & Mizelle, H. L. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i45 · Cited by 76
Self-citationDevice-Based Neuromodulation for Resistant Hypertension Therapy: Too Early for Prime Time?
Lohmeier, T. E., & Hall, J. E. (2019) · Circulation Research · doi:10.1161/circresaha.118.313221 · Cited by 76
Self-citationNyamdorj, R., Qiao, Q., Söderberg, S., Pitkäniemi, J., Zimmet, P., Shaw, J., Alberti, G., Nan, H., Uusitalo, U., Pauvaday, V., et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f624b7 · Cited by 75
Hyperinsulinemia: A link between obesity and hypertension?
Hall, J. E. (1993) · Kidney International · doi:10.1038/ki.1993.197 · Cited by 73
Self-citationGreenfield, J. R. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02088.x · Cited by 72
Jordan, J., Birkenfeld, A. L., Melander, O., & Moro, C. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11081 · Cited by 68
Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation
Kuo, J. J., da Silva, A. A., Tallam, L. S., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000111836.54204.93 · Cited by 68
Self-citationTreatment of Obesity in Mitigating Metabolic Risk
Heffron, S. P., Parham, J. S., Pendse, J., & Alemán, J. O. (2020) · Circulation Research · doi:10.1161/circresaha.119.315897 · Cited by 64
Gut hormones and gut microbiota: implications for kidney function and hypertension
Afsar, B., Vaziri, N. D., Aslan, G., Tarim, K., & Kanbay, M. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.10.007 · Cited by 63 · cited 3×
“Several gut hormones are influenced by GM, or their metabolites, and have various actions that could alter BP.(111) For example, glucagon-like”
BackgroundInfluentialMachleidt, F., Simon, P., Krapalis, A. F., Hallschmid, M., Lehnert, H., & Sayk, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3009 · Cited by 61
Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension
Dudenbostel, T., & Calhoun, D. A. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpw105 · Cited by 51
Singer, D. R. J., Markandu, N. D., Cappuccio, F. P., Miller, M. A., Sagnella, G. A., & MacGregor, G. A. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.1042 · Cited by 49
The Brain Melanocortin System, Sympathetic Control, and Obesity Hypertension
da Silva, A. A., do Carmo, J. M., Wang, Z., & Hall, J. E. (2014) · Physiology · doi:10.1152/physiol.00061.2013 · Cited by 47
Self-citationIliescu, R., Tudorancea, I., Irwin, E. D., & Lohmeier, T. E. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00464.2013 · Cited by 46 · cited 3×
“Cardiac and RSNA baroreflex sensitivities are reduced in obesityHT.(38,39,49) Iliescu et al.”
BackgroundTaylor, E. B., & Ryan, M. J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005394 · Cited by 45
do Carmo, J. M., da Silva, A. A., Ebaady, S. E., Sessums, P. O., Abraham, R. S., Elmquist, J. K., Lowell, B. B., & Hall, J. E. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00131.2014 · Cited by 43
Self-citationDavel, A. P., Jaffe, I. Z., Tostes, R. C., Jaisser, F., & de Chantemèle, E. J. B. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00073.2018 · Cited by 43
Hypothalamic and inflammatory basis of hypertension
Khor, S., & Cai, D. (2017) · Clinical Science · doi:10.1042/cs20160001 · Cited by 42
Obesity, Hypertension, and Bariatric Surgery
Samson, R., Ayinapudi, K., Jemtel, T. H. L., & Oparil, S. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01049-x · Cited by 41
do Carmo, J. M., da Silva, A. A., Rushing, J. S., & Hall, J. E. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00392.2011 · Cited by 39
Self-citationCui, Z., Truesdale, K. P., Bradshaw, P. T., Cai, J., & Stevens, J. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.56 · Cited by 38
Role of the brain melanocortins in blood pressure regulation
do Carmo, J. M., da Silva, A. A., Wang, Z., Fang, T., Aberdein, N., Perez de Lara, C. E., & Hall, J. E. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.003 · Cited by 38
Self-citationSeniuk, A., Thiele, J. L., Stubbe, A., Oser, P., Rosendahl, A., Bode, M., Meyer‐Schwesinger, C., Wenzel, U. O., & Ehmke, H. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.13773 · Cited by 38
Savoia, C., Volpe, M., Alonzo, A., Rossi, C., & Rubattu, S. (2010) · Clinical Science · doi:10.1042/cs20090204 · Cited by 35
Bomback, A. S., Muskala, P., Bald, E., Chwatko, G., & Nowicki, M. (2009) · Clinical Nephrology · doi:10.5414/cnp72449 · Cited by 34 · cited 1×
“Also, spironolactone reduced BP and urinary albumin excretion in obese hypertensive subjects even after blockade of AngII formation.(95) Compared to other antihypertensive drugs, the MR antagonist spiro-”
BackgroundCiriello, J., & Moreau, J. M. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00068.2012 · Cited by 33
Role of Aldosterone Blockade in Resistant Hypertension
Egan, B. M., & Li, J. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.04.004 · Cited by 33
do Carmo, J. M., da Silva, A. A., Wang, Z., Freeman, J. N., Alsheikh, A. J., Adi, A. H., & Hall, J. E. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06153 · Cited by 31
Self-citationChronic blood pressure and appetite responses to central leptin infusion in rats fed a high fat diet
Dubinion, J. H., da Silva, A. A., & Hall, J. E. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328344280b · Cited by 27
Self-citationChronic Interactions Between Carotid Baroreceptors and Chemoreceptors in Obesity Hypertension
Lohmeier, T. E., Iliescu, R., Tudorancea, I., Cazan, R., Cates, A. W., Georgakopoulos, D., & Irwin, E. D. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07232 · Cited by 27
do Carmo, J. M., da Silva, A. A., Sessums, P. O., Ebaady, S. H., Pace, B. R., Rushing, J. S., Davis, M. T., & Hall, J. E. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.177 · Cited by 26
Self-citationAdverse effects of short-term, very-low-salt diets in subjects with risk-factor clustering
Egan, B., & Stepniakowski, K. T. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.2.671s · Cited by 23
Khan, S. A., Sattar, M. Z. A., Abdullah, N. A., Rathore, H. A., Ahmad, A., Abdulla, M. H., & Johns, E. J. (2017) · Acta Physiologica · doi:10.1111/apha.12891 · Cited by 23
Aberdein, N., Dambrino, R. J., do Carmo, J. M., Wang, Z., Mitchell, L. E., Drummond, H. A., & Hall, J. E. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00287.2017 · Cited by 21
Self-citationRole of SOCS3 in POMC neurons in metabolic and cardiovascular regulation
Wang, Z., do Carmo, J. M., da Silva, A. A., Bailey, K. C., Aberdein, N., Moak, S. P., & Hall, J. E. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00163.2018 · Cited by 20
Self-citationdo Carmo, J. M., da Silva, A. A., Gava, F. N., Moak, S. P., Dai, X., & Hall, J. E. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00077.2019 · Cited by 19
Self-citationFrom Rags to Riches: Moving Beyond RAG1 in Studies of Hypertension
Madhur, M. S., Kirabo, A., Guzik, T. J., & Harrison, D. G. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14612 · Cited by 19
da Silva, A. A., do Carmo, J. M., Dubinion, J. H., Bassi, M., Mokhtarpouriani, K., Hamza, S. M., & Hall, J. E. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.03999 · Cited by 18
Self-citationBonfils, P. K., Taskiran, M., Damgaard, M., Goetze, J. P., Floyd, A. K., Funch-Jensen, P. M., Kristiansen, V. B., & Gadsbøll, N. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328363c769 · Cited by 16
Asferg, C. L., Andersen, U. B., Linneberg, A., Goetze, J. P., & Jeppesen, J. L. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy029 · Cited by 13
Fluid retention, aldosterone excess, and treatment of resistant hypertension
Calhoun, D. A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30080-9 · Cited by 11
Abdulle, A. M., Nagelkerke, N. J. D., Adem, A., Abouchacra, S., Pathan, J. Y., Al-Rukhaimi, M., Suleiman, M. N., Mathew, M. C., Nicholls, M. G., & Obineche, E. N. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002210 · Cited by 11
Chaudhary, P., & Schreihofer, A. M. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00195.2018 · Cited by 10
Cardiometabolic Surgery for Treatment of Hypertension?
Hall, J. E., & Hall, M. E. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12369 · Cited by 10
Self-citation
Cited by
Neeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463
Obesity and chronic kidney disease
Jiang, Z., Wang, Y., Zhao, X., Cui, H., Han, M., Ren, X., Gang, X., & Wang, G. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2022 · Cited by 267
Hammoud, S. H., AlZaim, I., Al-Dhaheri, Y., Eid, A. H., & El-Yazbi, A. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.707126 · Cited by 87
Packer, M., Zile, M. R., Kramer, C. M., Murakami, M., Ou, Y., & Borlaug, B. A. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.03.009 · Cited by 49
Metadata
- Authors
- Hall, J. E., Mouton, A. J., da Silva, A. A., Omoto, A. C. M., Wang, Z., Li, X., & do Carmo, J. M.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12-01
- Volume
- 117
- Issue
- 8
- Pages
- 1859-1876
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W3107928135
- Cited by
- 265
- References
- 166
- FWCI
- 11.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.